Alcon (ALC) Launches Clareon Portfolio in the US
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Futures ease as bond yields stay elevated amid Middle East tensions
- Johnson & Johnson (JNJ) posts mixed results, narrows full-year guidance
- UnitedHealth to take up to $1.6 billion hit from Change Healthcare hack this year
- Asian shares slide on Fed rate cut rethink; China GDP in focus
- China Q1 GDP grows 5.3%, more than expected
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- The Israeli Air Force Has Completed Its Preparation For An Imminent Attack Against Iran - Reuters
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
- After-hours movers: Alpine Immune Sciences, Costco, and more
- Midday movers: Delta, Taiwan Semiconductor rise; Hexcel falls
Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.
March 7, 2022 1:00 AM ESTClareon family of intraocular lenses (IOLs) delivers excellent vision, exceptional clarity and predictable refractive outcomes in a glistening-free§ IOL material1-3 Long-lasting clarity of the Clareon IOL and extensive real-world experience with excellent outcomes demonstrated in 30 peer-reviewed studies4-6 Global rollout of Clareon portfolio has started; U.S. to launch Clareon Monofocal, Clareon PanOptix and Clareon Vivity IOLs in March with additional countries planned throughout 2022
GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to... More
